learning
- 28 Feb 2013 21:08
There seems to be increasingly positive RNS on Angle PLC. It seems they have a world-leading cancer diagnostic kit that is now being tested by the key cancer research labs in the world. The potential research market is £250mn pa, and the commercial market is £7.9bn according to their presentations (on their website). The product follows the Gillette model of making money on the consumables not the equipment. The stock was tipped in Shares about three weeks ago. The company's market cap is £26mn. I am always nervous of the pharma/biotech/medtech area as I don't understand it properly. Anyone know the company, management or industry and have a view, please?
Balerboy
- 15 Jan 2014 23:19
- 10 of 13
4% spread though, not good.,.
required field
- 16 Jan 2014 09:33
- 11 of 13
Just get some Balerboy.....dare I call it the new Blur.....
BAYLIS
- 16 Jan 2014 15:02
- 12 of 13
CHECK OUT CNKS , LOTS OF IPOS ON THE WAY. CENKOS. A BLUR
required field
- 24 Jan 2014 09:18
- 13 of 13
Back on the rise again....